Ontology highlight
ABSTRACT:
SUBMITTER: Zhong H
PROVIDER: S-EPMC10173773 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
Zhong Huijuan H Cheng Shu S Zhang Xi X Xu Bing B Chen Jiayi J Jiang Xufeng X Xiong Jie J Hu Yu Y Cui Guohui G Wei Juying J Qian Wenbin W Huang Xiaobing X Hou Ming M Yan Feng F Wang Xin X Song Yongping Y Hu Jianda J Liu Yuanhua Y Ma Xuejun X Li Fei F Wu Chongyang C Chen Junmin J Yu Li L Bai Ou O Xu Jingyan J Zhu Zunmin Z Liu Li L Zhou Xin X Huang Li L Tong Yin Y Niu Ting T Wu Depei D Zhang Hao H Wang Chaofu C Ouyang Binshen B Yi Hongmei H Song Qi Q Cai Gang G Li Biao B Liu Jia J Li Zhifeng Z Xiao Rong R Wang Luqun L Jiang Yujie Y Liu Yanyan Y Zheng Xiaoyun X Xu Pengpeng P Huang Hengye H Wang Li L Chen Saijuan S Zhao Weili W
Innovation (Cambridge (Mass.)) 20230413 3
Methotrexate, etoposide, dexamethasone, and pegaspargase (MESA) with sandwiched radiotherapy is known to be effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type (NKTCL). We explored the efficacy and safety of reduced-intensity, non-intravenous etoposide, dexamethasone, and pegaspargase (ESA) with sandwiched radiotherapy. This multicenter, randomized, phase III trial enrolled patients aged between 14 and 70 years with newly diagnosed early-stage nasal NKTCL from 27 cent ...[more]